AbbVie
ABBV
#30
Rank
NZ$549.24 B
Marketcap
$310.81
Share price
2.37%
Change (1 day)
26.28%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of September 2024 : NZ$12.89 Billion

According to AbbVie's latest financial reports the company has NZ$12.89 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$20.26 B39.42%
2022-12-31NZ$14.53 B1.01%
2021-12-31NZ$14.39 B22.47%
2020-12-31NZ$11.75 B-80.18%
2019-12-31NZ$59.28 B393.28%
2018-12-31NZ$12.01 B-12.81%
2017-12-31NZ$13.78 B48.65%
2016-12-31NZ$9.27 B-24.51%
2015-12-31NZ$12.28 B14.93%
2014-12-31NZ$10.68 B-11.24%
2013-12-31NZ$12.04 B24.19%
2012-12-31NZ$9.69 B1058.81%
2011-12-31NZ$0.83 B5890.66%
2010-12-31NZ$13.96 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$17.61 B 36.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.32 B 11.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.22 B-51.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.95 B 23.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.91 B-30.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.00 B-76.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.60 B-40.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$8.72 B-32.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$2.17 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA